ClinConnect ClinConnect Logo
Search / Trial NCT05727085

Cohort of Twin Pregnancy and the Offspring

Launched by FUDAN UNIVERSITY · Feb 13, 2023

Trial Information

Current as of August 27, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying twin pregnancies to better understand the health risks that mothers and their babies may face. Twin pregnancies can lead to complications like high blood pressure, premature labor, and conditions that affect the growth of the babies. The researchers aim to learn more about the biological differences between twins and how these may impact their health both before and after birth. By gathering information from a group of twin pregnancies and their children, the study hopes to find new treatments and improve care for twin pregnancies.

If you are a woman over 18 years old and are currently expecting twins, you might be eligible to participate in this study. However, if either baby has a serious genetic condition or if there has been a stillbirth, you would not be able to join. Participants in the study will help provide valuable information that could lead to better health outcomes for future mothers and their twins. Your involvement could make a difference in understanding and improving care for twin pregnancies.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • 1. Maternal age \>18 years old.
  • 2. Twin pregnancy.
  • Exclusion Criteria:
  • 1. Fetal chromosomal or congenital abnormalities.
  • 2. Stillbirth.

About Fudan University

Fudan University, a prestigious comprehensive research university located in Shanghai, China, is committed to advancing medical science through innovative clinical research. Renowned for its rigorous academic standards and cutting-edge research facilities, Fudan University plays a pivotal role in the global health landscape by sponsoring a diverse array of clinical trials aimed at improving patient outcomes and addressing pressing medical challenges. Leveraging its multidisciplinary expertise and collaborative networks, the university strives to translate scientific discoveries into practical applications, fostering advancements in healthcare and contributing to the well-being of communities both locally and internationally.

Locations

Shanghai, Shanghai, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials